chr21-14964781-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_003489.4(NRIP1):āc.3412A>Gā(p.Ser1138Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00052 in 1,598,780 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003489.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRIP1 | NM_003489.4 | c.3412A>G | p.Ser1138Gly | missense_variant | 4/4 | ENST00000318948.7 | NP_003480.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NRIP1 | ENST00000318948.7 | c.3412A>G | p.Ser1138Gly | missense_variant | 4/4 | 2 | NM_003489.4 | ENSP00000327213 | P1 | |
NRIP1 | ENST00000400199.5 | c.3412A>G | p.Ser1138Gly | missense_variant | 3/3 | 3 | ENSP00000383060 | P1 | ||
NRIP1 | ENST00000400202.5 | c.3412A>G | p.Ser1138Gly | missense_variant | 3/3 | 5 | ENSP00000383063 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00292 AC: 444AN: 152186Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000805 AC: 190AN: 236110Hom.: 2 AF XY: 0.000650 AC XY: 83AN XY: 127604
GnomAD4 exome AF: 0.000270 AC: 390AN: 1446476Hom.: 1 Cov.: 32 AF XY: 0.000246 AC XY: 177AN XY: 719332
GnomAD4 genome AF: 0.00290 AC: 442AN: 152304Hom.: 2 Cov.: 32 AF XY: 0.00303 AC XY: 226AN XY: 74498
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.3412A>G (p.S1138G) alteration is located in exon 4 (coding exon 1) of the NRIP1 gene. This alteration results from a A to G substitution at nucleotide position 3412, causing the serine (S) at amino acid position 1138 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
NRIP1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 11, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at